Analysts Set Revance Therapeutics, Inc. (NASDAQ:RVNC) Target Price at $8.39
Shares of Revance Therapeutics, Inc. (NASDAQ:RVNC – Get Free Report) have received an average rating of “Hold” from the nine brokerages that are covering the company, MarketBeat Ratings reports. Eight equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The average 12 month […]
More Stories
Gun Used in Shooting Colombian Presidential Candidate Traced to Arizona
By Yeny Sora Robles The pistol used to shoot Colombian presidential candidate Sen. Miguel Uribe Turbay was purchased in the...
How Major US Stock Indexes Fared June 10
By The Associated Press U.S. stocks drifted just below their all-time high as the wait continues to hear what will...
Boston Red Sox Call Up Baseball’s No. 1 Prospect: Roman Anthony
By Ross Kelly Facing a rash of injuries, the Boston Red Sox have dipped into their farm system and promoted...
Japan Says China Sent 2 Aircraft Carriers in Pacific for First Time
By Dorothy Li Japan has confirmed that two Chinese aircraft carriers are simultaneously carrying out operations in the Pacific for...
Thomas Massie Introduces Bill to Audit America’s Gold Reserves
By Andrew Moran Rep. Thomas Massie (R-Ky.) introduced legislation on June 6 to audit gold reserves held by the United...
Sivia Capital Partners LLC Takes $214,000 Position in Illinois Tool Works Inc. (NYSE:ITW)
Sivia Capital Partners LLC acquired a new stake in shares of Illinois Tool Works Inc. (NYSE:ITW – Free Report) during...